» Articles » PMID: 34773253

NLRP3 Knockout Enhances Immune Infiltration and Inflammatory Responses and Improves Survival in a Burn Sepsis Model

Overview
Journal Immunology
Date 2021 Nov 13
PMID 34773253
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Although sepsis in burn patients is a major contributor to mortality, treatments are not always effective and underlying mechanisms have yet to be completely elucidated. NLRP3 inflammasome orchestrates burn-induced, inflammatory-driven pathophysiologic processes. Here, we determined the mechanism of NLRP3 inflammasome activation on bacterial clearance and mortality in burn sepsis. We obtained tissue and blood from 30 wild-type and 30 Nlrp3 mice. Mice were subjected to a two-hit model of 25-30% TBSA scald burn followed by Pseudomonas aeruginosa wound infection 72 hours after injury. We also obtained tissue from 34 adult burn patients (≥18 years of age) with early (0-11 days post-burn) and later (≥12 days post-burn) surgical time-points and ten healthy controls. Murine studies indicated that Nlrp3 had 30% improved survival and bacterial clearance at the site of injury and is systemically relative to burn sepsis wild type. Greater macrophage and neutrophil infiltration occurred acutely after infection (12 hours) to the site of injury and adipose tissue. This was followed by increased macrophage and neutrophil infiltration to lymphoid organs and liver beyond the acute phase (24 and 72 hours). Interestingly, Nlrp3 ablation increased acute systemic inflammation (IL-6, TNF-α, IL-1β). Septic burn patients had persistently increased adipose NLRP3 by-product expression beyond the acute phase that was more pronounced in late-onset sepsis. Our findings suggest that Nlrp3 genetic ablation enhanced acute tissue-specific inflammatory responsiveness. Likely, this occurs by paradoxically increasing acute immune infiltration and inflammation with a non-persistent response. Clinically, persistent NLRP3-mediated inflammation occurs in septic versus normal burn patients and potentially detrimentally impacts patient outcomes.

Citing Articles

Study on metabolic disorders in rat liver induced by different times after scalds.

Chen Z, Lin H, Su X, Xu W, Fang W, Ruan G Biochem Biophys Rep. 2025; 41():101904.

PMID: 39811192 PMC: 11732185. DOI: 10.1016/j.bbrep.2024.101904.


NLRP3 and AIM2 inflammasomes expression is modified by LPS and titanium ions increasing the release of active IL-1β in alveolar bone-derived MSCs.

Carrillo-Galvez A, Zurita F, Guerra-Valverde J, Aguilar-Gonzalez A, Abril-Garcia D, Padial-Molina M Stem Cells Transl Med. 2024; 13(8):826-841.

PMID: 39013640 PMC: 11328940. DOI: 10.1093/stcltm/szae042.


The NLRP3 inflammasome in burns: a novel potential therapeutic target.

Li H, Zhao J, Cao L, Luo Q, Zhang C, Zhang L Burns Trauma. 2024; 12:tkae020.

PMID: 38957662 PMC: 11218784. DOI: 10.1093/burnst/tkae020.


Effect of Hydrogen on AM Pyroptosis Induced by Severe Burns in Rats.

Luo N, Lin H, Zhang L, Jiang Y, Zhao Y, Han Q J Pers Med. 2023; 13(3).

PMID: 36983559 PMC: 10053548. DOI: 10.3390/jpm13030377.


Glutamine mitigates murine burn sepsis by supporting macrophage M2 polarization through repressing the SIRT5-mediated desuccinylation of pyruvate dehydrogenase.

Zhu Y, Chen X, Lu Y, Xia L, Fan S, Huang Q Burns Trauma. 2023; 10:tkac041.

PMID: 36601059 PMC: 9801296. DOI: 10.1093/burnst/tkac041.


References
1.
Hotchkiss R, Monneret G, Payen D . Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis. 2013; 13(3):260-8. PMC: 3798159. DOI: 10.1016/S1473-3099(13)70001-X. View

2.
Church D, Elsayed S, Reid O, Winston B, Lindsay R . Burn wound infections. Clin Microbiol Rev. 2006; 19(2):403-34. PMC: 1471990. DOI: 10.1128/CMR.19.2.403-434.2006. View

3.
Murphy T, Paterson H, Kriynovich S, Zang Y, Kurt-Jones E, Mannick J . Linking the "two-hit" response following injury to enhanced TLR4 reactivity. J Leukoc Biol. 2004; 77(1):16-23. DOI: 10.1189/jlb.0704382. View

4.
Barker B, Taxman D, Ting J . Cross-regulation between the IL-1β/IL-18 processing inflammasome and other inflammatory cytokines. Curr Opin Immunol. 2011; 23(5):591-7. PMC: 3380339. DOI: 10.1016/j.coi.2011.07.005. View

5.
Hodle A, Richter K, Thompson R . Infection control practices in U.S. burn units. J Burn Care Res. 2006; 27(2):142-51. DOI: 10.1097/01.BCR.0000203493.31642.79. View